Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

M Bonferroni

Showing results (11-20 of 13) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 13 results.
European Journal of Cancer & Clinical Oncology|February 1, 1988
Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN)F Lauria, R Foà, D Raspadori, et al.
Leukemia|January 1, 1988
In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activityM T Fierro, X S Liao, P Lusso, et al.
Blood|October 1, 1990
Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectorsR Foa, M T Fierro, D Raspadori, et al.
Pageof 2

Showing results (11-20 of 13) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 13 results.
European Journal of Cancer & Clinical Oncology|February 1, 1988
Treatment of hairy-cell leukaemia with alpha-interferon (alpha-IFN)F Lauria, R Foà, D Raspadori, et al.
Leukemia|January 1, 1988
In vitro and in vivo susceptibility of human leukemic cells to lymphokine activated killer activityM T Fierro, X S Liao, P Lusso, et al.
Blood|October 1, 1990
Lymphokine-activated killer (LAK) cell activity in B and T chronic lymphoid leukemia: defective LAK generation and reduced susceptibility of the leukemic cells to allogeneic and autologous LAK effectorsR Foa, M T Fierro, D Raspadori, et al.
Pageof 2